Dow IncDow is reportedly weighing a sale of its 35% Sadara stake, a portfolio-reshaping move that could bring cash but forfeit recovery upside.

Dow Inc. is reportedly considering selling its 35% stake in Sadara Chemical, its $20 billion chemicals joint venture with Saudi Aramco, as the company continues to reshape its portfolio amid a prolonged downturn in the global chemicals industry. No final decision has been made, and Aramco or another strategic or financial investor could potentially acquire Dow's stake. As of June 30, Dow had a negative investment balance of $793 million in Sadara and had suspended recognition of its share of the venture's equity losses in the first quarter, and the company has also been exposed to Sadara's financing obligations. Sadara remains a major industrial asset, operating a complex in Jubail with more than 3 million metric tons of annual chemicals and plastics capacity, though its operations were disrupted earlier this year by the Middle East conflict. In March, CEO Jim Fitterling said Dow's goal was to avoid putting additional cash into Sadara during 2026, describing the venture as having low operating cash costs but more challenging fixed costs and financing obligations. The $20 billion figure represents the original scale of the joint venture, not the current market value of Dow's 35% stake, so an exit could deliver less financial relief than the headline number suggests while forfeiting upside if chemical margins eventually recover.
Dow IncDow is reportedly weighing a sale of its 35% Sadara stake, a portfolio-reshaping move that could bring cash but forfeit recovery upside.
Sadara is the JV at the center of the potential stake sale, with Dow's negative $793M investment balance and suspended equity-loss recognition.
Aramco is named as a potential acquirer of Dow's 35% Sadara stake, but no decision or deal is confirmed.